Survival of patients with severe congestive heart failure treated with oral milrinone.

[1]  S. Geraci,et al.  Electrophysiologic effects of milrinone in patients with congestive heart failure. , 1986, The American journal of cardiology.

[2]  D. Baim,et al.  Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. , 1986, Circulation.

[3]  D. Baim,et al.  Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. , 1986, Circulation.

[4]  E. Braunwald,et al.  Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. , 1986, Circulation.

[5]  R. Cody,et al.  Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. , 1985, Journal of the American College of Cardiology.

[6]  H. White,et al.  Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. , 1985, The American journal of cardiology.

[7]  D. Baim,et al.  Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. , 1985, Circulation.

[8]  B. Massie,et al.  Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. , 1985, Circulation.

[9]  E. Braunwald,et al.  Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease. , 1985, The American journal of cardiology.

[10]  C. Furberg,et al.  Effect of vasodilators on survival in chronic congestive heart failure. , 1985, The American journal of cardiology.

[11]  R. Cody,et al.  Acute dose range study of milrinone in congestive heart failure. , 1985, The American journal of cardiology.

[12]  E. Braunwald,et al.  Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. , 1985, The Journal of clinical investigation.

[13]  P. Kligfield,et al.  Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. , 1985, The American journal of cardiology.

[14]  D. Baim,et al.  Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. , 1984, Circulation.

[15]  M. Packer,et al.  Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. , 1984, Circulation.

[16]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[17]  M. Moeschberger,et al.  Factors influencing the one-year mortality of dilated cardiomyopathy. , 1984, The American journal of cardiology.

[18]  E. Braunwald,et al.  Evaluating the efficacy of new inotropic agents. , 1984, Journal of the American College of Cardiology.

[19]  E. Sonnenblick,et al.  Should the failing heart be stimulated? , 1984, The New England journal of medicine.

[20]  T. LeJemtel,et al.  High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. , 1984, American heart journal.

[21]  C. Antzelevitch,et al.  The effects of milrinone on conduction, reflection, and automaticity in canine Purkinje fibers. , 1984, Circulation.

[22]  T. Meinertz,et al.  Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. , 1984, The American journal of cardiology.

[23]  M. Packer,et al.  Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism. , 1983, Journal of the American College of Cardiology.

[24]  E. Braunwald,et al.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. , 1983, The New England journal of medicine.

[25]  R. Ferrari,et al.  Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals , 1983, Journal of cardiovascular pharmacology.

[26]  L. Horowitz,et al.  Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. , 1983, Journal of the American College of Cardiology.

[27]  E. Sonnenblick,et al.  Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease. , 1983, Journal of the American College of Cardiology.

[28]  E. Sonnenblick,et al.  Sustained Hemodynamic and Clinical Effects of a New Cardiotonic Agent, WIN 47203, in Patients with Severe Congestive Heart Failure , 1983, Circulation.

[29]  J. Cohn,et al.  Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[30]  R. Magorien,et al.  The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. , 1983, American heart journal.

[31]  J. Halperin,et al.  Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. , 1982, American heart journal.

[32]  B. Greenberg,et al.  Results of Long‐term Vasodilator Therapy in Patients with Refractory Congestive Heart Failure , 1981, Circulation.

[33]  W. J. Dixon,et al.  BMDP-79, biomedical computer programs, P-series , 1981 .

[34]  V. Fuster,et al.  The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.

[35]  B. Massie,et al.  Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.

[36]  A. Katz.  A new inotropic drug: its promise and a caution. , 1978, The New England journal of medicine.

[37]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[38]  D. Littmann.  The natural history of congestive heart failure. , 1971, The New England journal of medicine.

[39]  N. Breslow.  A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .

[40]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[41]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .